Intelligence · Clinical Pipeline
BRIGHT MINDS BIOSCIENCES Pipeline
All ClinicalTrials.gov programs at BRIGHT MINDS BIOSCIENCES — phase, modality, and trial IDs.
- Programs
- 393
Quick answer
BRIGHT MINDS BIOSCIENCES has 393 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.
-
sunitinib added to FOLFIRI
BRIGHT MINDS BIOSCIENCES INC.
Metastatic Colorectal Cancer
1 trial -
telephone based skills training intervention
BRIGHT MINDS BIOSCIENCES INC.
Smoking Cessation
1 trial -
topiramate
BRIGHT MINDS BIOSCIENCES INC.
Cocaine Dependence
1 trial -
tramadol
BRIGHT MINDS BIOSCIENCES INC.
Opioid Abuse
1 trial -
transdermal nicotine
BRIGHT MINDS BIOSCIENCES INC.
Cigarette Smoking
1 trial -
varenicline
BRIGHT MINDS BIOSCIENCES INC.
Alcoholism
1 trial -
widow spider antivenom
BRIGHT MINDS BIOSCIENCES INC.
Arachnidism
1 trial -
xue-fu-zhu-yu capsule
BRIGHT MINDS BIOSCIENCES INC.
Qi Stagnation and Blood Stasis Syndrome
1 trial -
zonisamide
BRIGHT MINDS BIOSCIENCES INC.
Nicotine Dependence
1 trial
Frequently asked questions
How many pipeline programs does BRIGHT MINDS BIOSCIENCES have?
393 published programs are linked to this sponsor in our ClinicalTrials.gov index.
Is this the complete company pipeline?
This hub lists all published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.
Data attribution: Data sources · All pipeline programs